| 16.58 Data as of May 23 |  +0.02 / +0.12%Today’s Change | 10.15 Today|||52-Week Range 16.70 | +21.55% Year-to-Date |
| Previous close | 16.56 |
| Today’s open | 16.53 |
| Day’s range | 16.53 - 16.64 |
| Volume | 62,299 |
| Average volume (3 months) | 159,127 |
| Market cap | $390.5M |
| Dividend yield | -- |
| Earnings growth (last year) | -4.89% |
| Earnings growth (this year) | -8.05% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +26.56% |
| P/E ratio | -- |
| Price/Sales | 2.84 |
| Price/Book | 1.68 |
| Today’s change | Today’s % change | |
|---|---|---|
| INSMInsmed Inc | 0.00 | 0.00% |
| GTXIGTX Inc | +0.18 | +2.86% |
| NLNKNewLink Genetics Cor... | +0.50 | +3.22% |
| FURXFuriex Pharmaceutica... | +0.37 | +0.94% |
| Last reporting date | May 20, 2013 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $106.3M |
| Annual profit (last year) | $16.2M |
| Net profit margin | 15.28% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Jing Lou, MD, PhD |
CFO & Investor Relations Contact Bo Tan, MBA |
Corporate headquarters Shenyang, Liaoning |
.
